Nosebleed recurrence prognostic factors

Detalhes bibliográficos
Autor(a) principal: Laffont, João
Data de Publicação: 2017
Outros Autores: Melo, Ana Sofia, Caiado, Ricardo, Casalta, João, Ribeiro, João Carlos, Ribeiro, Carlos, Paiva, António Diogo
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
DOI: 10.34631/sporl.387
Texto Completo: https://doi.org/10.34631/sporl.387
Resumo: Objectives: To evaluate nosebleed recurrence prognostic factors.Study Design: Retrospective observational studyMaterial e Methods: Inclusion criteria was nosebleed in ENT emergency department in 2013. Correlation with recurrence was tested for pathologic factors, nosebleed characteristics, treatment methods, seasonality, climacteric conditions, demographic factors, recommendations and hospital admittance need.Results: We observed 549 nosebleed episodes from 396 patients with 27.9% recurrence episodes. In 17.3% patients were prescribed anticoagulants; 39.3% the nosebleed was active in the ED and hospital admittance was necessary in 9.8%. Recurrence prognostic factors included, anticoagulant medication, active nosebleed, coagulation disorders and smoking. Hospital admittance was a recurrence protective factor. No association between recurrence and any of the used techniques was identified.Conclusions: Nosebleed recurrence negative prognostic factors included anticoagulant use, previous coagulation disorders, active nosebleed and active smoking. Hospital admittance was a positive prognostic factor. It’s of utmost importance to have them in consideration during nosebleed management.
id RCAP_1efcff358d3ac6386bf5954ac884d44d
oai_identifier_str oai:journalsporl.com:article/2810
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Nosebleed recurrence prognostic factorsFactores De Prognóstico De Recidiva Na EpistáxisNosebleedrecurrenceprognostic factorsEpistáxisrecidivafactores prognósticosObjectives: To evaluate nosebleed recurrence prognostic factors.Study Design: Retrospective observational studyMaterial e Methods: Inclusion criteria was nosebleed in ENT emergency department in 2013. Correlation with recurrence was tested for pathologic factors, nosebleed characteristics, treatment methods, seasonality, climacteric conditions, demographic factors, recommendations and hospital admittance need.Results: We observed 549 nosebleed episodes from 396 patients with 27.9% recurrence episodes. In 17.3% patients were prescribed anticoagulants; 39.3% the nosebleed was active in the ED and hospital admittance was necessary in 9.8%. Recurrence prognostic factors included, anticoagulant medication, active nosebleed, coagulation disorders and smoking. Hospital admittance was a recurrence protective factor. No association between recurrence and any of the used techniques was identified.Conclusions: Nosebleed recurrence negative prognostic factors included anticoagulant use, previous coagulation disorders, active nosebleed and active smoking. Hospital admittance was a positive prognostic factor. It’s of utmost importance to have them in consideration during nosebleed management.Objectivos: Avaliar os factores clínicos prognósticos de recidiva de epistáxis.Desenho do estudo: Estudo retrospectivo.Materiais e Métodos: Foram incluídos os doentes que recorreram ao SU-CHUC no ano 2013 por epistáxis. Foi testada a correlação entre recidiva de epistáxis e antecedentes pessoais, características da epistáxis, métodos de tratamento, sazonalidade, clima, demografia, recomendações pós-alta e internamento.Resultados: Observaram-se 549 episódios de 396 doentes com 27.9% de episódios de recidiva. Verificou-se anticoagulação em 17,3%, epistáxis activa em 39,3% e internamento em 9,8%.Foram identificados como factores prognósticos de maior recidiva de epistáxis a anticoagulação, epistáxis activa, coagulopatia e tabagismo. O internamento foi um factor protector de recidiva. Não houve associação entre recidiva e nenhuma das técnicas utilizadas.Conclusões: A anticoagulação, coagulopatia, epistáxis activa e tabagismo activo foram identificados como factores predisponentes e o internamento como factor protector. É importante conhecer os factores de risco hemorrágico na orientação terapêutica da epistáxis.Sociedade Portuguesa de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço2017-05-07info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documenthttps://doi.org/10.34631/sporl.387https://doi.org/10.34631/sporl.387Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery; Vol. 54 No. 2 (2016): Junho; 119-124Revista Portuguesa de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço; Vol. 54 Núm. 2 (2016): Junho; 119-124Revista Portuguesa de Otorrinolaringologia-Cirurgia de Cabeça e Pescoço; Vol. 54 N.º 2 (2016): Junho; 119-1242184-6499reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://journalsporl.com/index.php/sporl/article/view/2810https://journalsporl.com/index.php/sporl/article/view/2810/824https://journalsporl.com/index.php/sporl/article/view/2810/825Laffont, JoãoMelo, Ana SofiaCaiado, RicardoCasalta, JoãoRibeiro, João CarlosRibeiro, CarlosPaiva, António Diogoinfo:eu-repo/semantics/openAccess2024-06-06T13:00:19Zoai:journalsporl.com:article/2810Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-06-06T13:00:19Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Nosebleed recurrence prognostic factors
Factores De Prognóstico De Recidiva Na Epistáxis
title Nosebleed recurrence prognostic factors
spellingShingle Nosebleed recurrence prognostic factors
Nosebleed recurrence prognostic factors
Laffont, João
Nosebleed
recurrence
prognostic factors
Epistáxis
recidiva
factores prognósticos
Laffont, João
Nosebleed
recurrence
prognostic factors
Epistáxis
recidiva
factores prognósticos
title_short Nosebleed recurrence prognostic factors
title_full Nosebleed recurrence prognostic factors
title_fullStr Nosebleed recurrence prognostic factors
Nosebleed recurrence prognostic factors
title_full_unstemmed Nosebleed recurrence prognostic factors
Nosebleed recurrence prognostic factors
title_sort Nosebleed recurrence prognostic factors
author Laffont, João
author_facet Laffont, João
Laffont, João
Melo, Ana Sofia
Caiado, Ricardo
Casalta, João
Ribeiro, João Carlos
Ribeiro, Carlos
Paiva, António Diogo
Melo, Ana Sofia
Caiado, Ricardo
Casalta, João
Ribeiro, João Carlos
Ribeiro, Carlos
Paiva, António Diogo
author_role author
author2 Melo, Ana Sofia
Caiado, Ricardo
Casalta, João
Ribeiro, João Carlos
Ribeiro, Carlos
Paiva, António Diogo
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Laffont, João
Melo, Ana Sofia
Caiado, Ricardo
Casalta, João
Ribeiro, João Carlos
Ribeiro, Carlos
Paiva, António Diogo
dc.subject.por.fl_str_mv Nosebleed
recurrence
prognostic factors
Epistáxis
recidiva
factores prognósticos
topic Nosebleed
recurrence
prognostic factors
Epistáxis
recidiva
factores prognósticos
description Objectives: To evaluate nosebleed recurrence prognostic factors.Study Design: Retrospective observational studyMaterial e Methods: Inclusion criteria was nosebleed in ENT emergency department in 2013. Correlation with recurrence was tested for pathologic factors, nosebleed characteristics, treatment methods, seasonality, climacteric conditions, demographic factors, recommendations and hospital admittance need.Results: We observed 549 nosebleed episodes from 396 patients with 27.9% recurrence episodes. In 17.3% patients were prescribed anticoagulants; 39.3% the nosebleed was active in the ED and hospital admittance was necessary in 9.8%. Recurrence prognostic factors included, anticoagulant medication, active nosebleed, coagulation disorders and smoking. Hospital admittance was a recurrence protective factor. No association between recurrence and any of the used techniques was identified.Conclusions: Nosebleed recurrence negative prognostic factors included anticoagulant use, previous coagulation disorders, active nosebleed and active smoking. Hospital admittance was a positive prognostic factor. It’s of utmost importance to have them in consideration during nosebleed management.
publishDate 2017
dc.date.none.fl_str_mv 2017-05-07
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://doi.org/10.34631/sporl.387
https://doi.org/10.34631/sporl.387
url https://doi.org/10.34631/sporl.387
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://journalsporl.com/index.php/sporl/article/view/2810
https://journalsporl.com/index.php/sporl/article/view/2810/824
https://journalsporl.com/index.php/sporl/article/view/2810/825
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/vnd.openxmlformats-officedocument.wordprocessingml.document
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço
publisher.none.fl_str_mv Sociedade Portuguesa de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço
dc.source.none.fl_str_mv Portuguese Journal of Otorhinolaryngology and Head and Neck Surgery; Vol. 54 No. 2 (2016): Junho; 119-124
Revista Portuguesa de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço; Vol. 54 Núm. 2 (2016): Junho; 119-124
Revista Portuguesa de Otorrinolaringologia-Cirurgia de Cabeça e Pescoço; Vol. 54 N.º 2 (2016): Junho; 119-124
2184-6499
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1822183192327618560
dc.identifier.doi.none.fl_str_mv 10.34631/sporl.387